IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sofinnova Investments, Inc.

Q2 2025 Holdings

Filed 2025-08-14 | 63 holdings | $1.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Intuitive Surgical Inc(ISRG)COM46120E602$38.4M70,6422.3%
BridgeBio Pharma Inc(BBIO)COM10806X102$42.9M993,0932.6%
Ideaya Biosciences Inc(IDYA)COM45166A102$45.1M2,147,7952.8%
Dexcom Inc(DXCM)COM252131107$45.7M523,6942.8%
Boston Scientific Corp(BSX)COM101137107$46.3M431,2002.8%
iShares TR(IBB)PutISHARES BIOTECH464287556$47.4M375,0002.9%
AbbVie Inc(ABBV)COM00287Y109$49.3M265,8503.0%
iShares TR(IWM)PutRUSSELL 2000 ETF464287655$53.9M250,0003.3%
Vera Therapeutics Inc(VERA)CL A92337R101$65.8M2,793,9874.0%
Jazz Pharmaceuticals PLC(JAZZ)SHS USDG50871105$73.7M694,0964.5%
Eli Lilly and Co(LLY)COM532457108$75.6M97,0184.6%
Gilead Sciences Inc(GILD)COM375558103$116.4M1,050,3087.1%
Natera Inc(NTRA)COM632307104$261.9M1,550,28016.0%
PreviousPage 2 of 2